66 results
-
Proposed changes to the recommended use of human papillomavirus (HPV) vaccines
The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to the HPV vaccination recommendations for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992. The draft recommendations and the rationale for the changes are outlined in the... MoreClosed 30 November 2017 -
Public submissions to the five year review of the Health Star Rating system
Introduction The Health Star Rating (HSR) Advisory Committee (HSRAC), responsible for overseeing the implementation, monitoring and evaluation of the HSR system, is undertaking a five year review of the HSR system. The HSR system is a front-of-pack labelling (FoPL) scheme intended to assist consumers in making healthier diet choices. The findings of the review will be provided to the Australia and New Zealand Ministerial Forum on Food Regulation (Forum) in mid‑2019. In parallel... MoreClosed 17 August 2017 -
Pharmacy Review - Submissions to the Interim Report
Submit your response to the Interim Report The Panel for the Review of Pharmacy Remuneration and Regulation welcomes feedback on the reform options presented in its Interim Report. The issues contained in the Interim Report are complex, with the potential to impact significantly on community pharmacy. For this reason, the Panel invites you to provide any feedback on the proposed options and new information that may warrant consideration as the Panel deliberates on its Final Report.... MoreClosed 23 July 2017 -
Pharmacy Review - Responses to the Interim Report
The Interim Report presents the findings and options for reform arising from the Review of Pharmacy Remuneration and Regulation. The issues in this report are complex, with the potential to impact significantly on community pharmacy. For this reason, the Review Panel invites you to provide any feedback on the proposed options and new information that may warrant consideration as the Panel develops its Final Report. It is necessary that evidence is provided to support all considerations and... MoreClosed 23 July 2017 -
Medical Research Future Fund consultation for the development of the Australian Medical Research and Innovation Strategy and related Priorities
This phase of the consultation process is now closed. The Australian Medical Research Advisory Board held its first meeting at Parliament House on 4 May 2016. Under the Medical Research Future Fund Act 2015, the Advisory Board is tasked with determining the Australian Medical Research and Innovation Strategy (Strategy) and related Priorities. The Strategy is determined every five years and the Priorities every two years. Members of the Advisory Board want to work with the community to... MoreClosed 6 June 2016 -
Pharmacy Trial Program
The Australian Government recognises the important role that the pharmacy profession can play in primary care and in improving patient health outcomes. Primary health care plays an important role in broader population health. Primary health care providers, whether general practitioners, allied health professionals, Aboriginal health workers, nurses, pharmacists or other providers all play an important role in health promotion, prevention of chronic disease, risk assessment and early... MoreClosed 29 April 2016
66 results.
Page 3 of 3